62 related articles for article (PubMed ID: 9580043)
1. [Long-term prognosis for patients undergoing thrombolysis during the acute phase of myocardial infarction].
Bosset AJ; Vogt P; Eeckhout E; van Melle G; Monnier P; Schaller MD; Stauffer JC; Kappenberger L; Goy JJ
Ann Cardiol Angeiol (Paris); 1997; 46(5-6):303-10. PubMed ID: 9295890
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
3. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
4. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent.
Loubeyre C; Lefèvre T; Louvard Y; Dumas P; Piéchaud JF; Lanore JJ; Angellier JF; Le Tarnec JY; Karrillon G; Margenet A; Pougès C; Morice MC
Eur Heart J; 2001 Jul; 22(13):1128-35. PubMed ID: 11428853
[TBL] [Abstract][Full Text] [Related]
5. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
6. [Influence of systemic arterial hypertension on mid-term survival of patients with acute myocardial infarction treated with fibrinolytic agents].
Martínez Sande JL; González-Juanatey JR; García-Acuña JM; Amaro Cendón A; Fernández Vázquez F; Fernández López JA; García Seara J; Vega Fernández JM; López Lago A; Gil de la Peña M
Med Clin (Barc); 1997 Oct; 109(14):532-7. PubMed ID: 9580043
[TBL] [Abstract][Full Text] [Related]
7. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.
Grines C; Patel A; Zijlstra F; Weaver WD; Granger C; Simes RJ;
Am Heart J; 2003 Jan; 145(1):47-57. PubMed ID: 12514654
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in the outcome of cardiac interventions.
Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
[TBL] [Abstract][Full Text] [Related]
9. Effects of thrombolytic agents on coronary recanalization and patency, cardiac enzyme release, left ventricular function, and mortality in patients with acute myocardial infarction.
Verstraete M
J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S38-48. PubMed ID: 2483231
[TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic therapy in fresh myocardial infarct].
Hugenholtz PG; Simoons ML; Serruys PW; Suryapranata H; Vermeer F; Lubsen J
Wien Med Wochenschr; 1987 Nov; 137(22):506-12. PubMed ID: 3324496
[TBL] [Abstract][Full Text] [Related]
11. Unresolved issues after the available comparative trials of thrombolytic agents in acute myocardial infarction.
Collen D
Z Kardiol; 1993; 82 Suppl 2():119-23. PubMed ID: 8328188
[TBL] [Abstract][Full Text] [Related]
12. [Acute myocardial infarction mortality in a hospital department during the last decades].
Katona A; Deli L; Hutter K
Orv Hetil; 1995 Jun; 136(25):1319-22. PubMed ID: 7596590
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
